nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCG2—breast cancer	0.135	0.425	CbGaD
Vismodegib—CYP3A4—breast cancer	0.0674	0.213	CbGaD
Vismodegib—ALB—breast cancer	0.0588	0.185	CbGaD
Vismodegib—ABCB1—breast cancer	0.0561	0.177	CbGaD
Vismodegib—CYP2C9—Anastrozole—breast cancer	0.0171	0.042	CbGbCtD
Vismodegib—CYP2C8—Lapatinib—breast cancer	0.0163	0.0402	CbGbCtD
Vismodegib—ABCG2—Tamoxifen—breast cancer	0.0154	0.0378	CbGbCtD
Vismodegib—ABCB1—Toremifene—breast cancer	0.0152	0.0373	CbGbCtD
Vismodegib—ABCG2—Mitoxantrone—breast cancer	0.015	0.0369	CbGbCtD
Vismodegib—CYP2C19—Lapatinib—breast cancer	0.0137	0.0337	CbGbCtD
Vismodegib—CYP3A4—Exemestane—breast cancer	0.0131	0.0323	CbGbCtD
Vismodegib—CYP2C9—Idarubicin—breast cancer	0.0129	0.0319	CbGbCtD
Vismodegib—CYP2C8—Raloxifene—breast cancer	0.0124	0.0305	CbGbCtD
Vismodegib—ABCG2—Paclitaxel—breast cancer	0.012	0.0294	CbGbCtD
Vismodegib—ABCG2—Irinotecan—breast cancer	0.0118	0.029	CbGbCtD
Vismodegib—ABCG2—Fluorouracil—breast cancer	0.0113	0.0279	CbGbCtD
Vismodegib—ABCG2—Carboplatin—breast cancer	0.0112	0.0277	CbGbCtD
Vismodegib—CYP3A4—Letrozole—breast cancer	0.0111	0.0274	CbGbCtD
Vismodegib—ABCB1—Lapatinib—breast cancer	0.0111	0.0272	CbGbCtD
Vismodegib—CYP3A4—Anastrozole—breast cancer	0.00993	0.0244	CbGbCtD
Vismodegib—CYP3A4—Toremifene—breast cancer	0.00908	0.0224	CbGbCtD
Vismodegib—ABCG2—Docetaxel—breast cancer	0.00864	0.0213	CbGbCtD
Vismodegib—CYP3A4—Fulvestrant—breast cancer	0.00844	0.0208	CbGbCtD
Vismodegib—CYP2C8—Tamoxifen—breast cancer	0.00818	0.0201	CbGbCtD
Vismodegib—ALB—Irinotecan—breast cancer	0.00813	0.02	CbGbCtD
Vismodegib—ALB—Fluorouracil—breast cancer	0.0078	0.0192	CbGbCtD
Vismodegib—CYP3A4—Thiotepa—breast cancer	0.00753	0.0185	CbGbCtD
Vismodegib—CYP2C9—Capecitabine—breast cancer	0.00709	0.0175	CbGbCtD
Vismodegib—CYP3A4—Ixabepilone—breast cancer	0.00688	0.0169	CbGbCtD
Vismodegib—CYP2C19—Tamoxifen—breast cancer	0.00686	0.0169	CbGbCtD
Vismodegib—CYP3A4—Lapatinib—breast cancer	0.00663	0.0163	CbGbCtD
Vismodegib—ABCG2—Doxorubicin—breast cancer	0.00644	0.0159	CbGbCtD
Vismodegib—CYP2C8—Paclitaxel—breast cancer	0.00637	0.0157	CbGbCtD
Vismodegib—ABCG2—Methotrexate—breast cancer	0.00624	0.0154	CbGbCtD
Vismodegib—ABCB1—Vinorelbine—breast cancer	0.00613	0.0151	CbGbCtD
Vismodegib—CYP2C8—Fluorouracil—breast cancer	0.00603	0.0148	CbGbCtD
Vismodegib—CYP2C9—Tamoxifen—breast cancer	0.00571	0.014	CbGbCtD
Vismodegib—ABCB1—Tamoxifen—breast cancer	0.00554	0.0136	CbGbCtD
Vismodegib—ABCB1—Mitoxantrone—breast cancer	0.0054	0.0133	CbGbCtD
Vismodegib—CYP3A4—Raloxifene—breast cancer	0.00502	0.0124	CbGbCtD
Vismodegib—ABCB1—Gemcitabine—breast cancer	0.00477	0.0117	CbGbCtD
Vismodegib—CYP2C9—Paclitaxel—breast cancer	0.00444	0.0109	CbGbCtD
Vismodegib—ABCB1—Paclitaxel—breast cancer	0.00431	0.0106	CbGbCtD
Vismodegib—ALB—Methotrexate—breast cancer	0.0043	0.0106	CbGbCtD
Vismodegib—ABCB1—Irinotecan—breast cancer	0.00425	0.0105	CbGbCtD
Vismodegib—CYP2C9—Fluorouracil—breast cancer	0.0042	0.0104	CbGbCtD
Vismodegib—ABCB1—Vinblastine—breast cancer	0.00378	0.00931	CbGbCtD
Vismodegib—CYP3A4—Vinorelbine—breast cancer	0.00367	0.00905	CbGbCtD
Vismodegib—CYP3A4—Tamoxifen—breast cancer	0.00332	0.00817	CbGbCtD
Vismodegib—CYP3A4—Mitoxantrone—breast cancer	0.00324	0.00797	CbGbCtD
Vismodegib—ABCB1—Docetaxel—breast cancer	0.00312	0.00767	CbGbCtD
Vismodegib—CYP3A4—Paclitaxel—breast cancer	0.00258	0.00636	CbGbCtD
Vismodegib—SMO—mammary gland—breast cancer	0.00257	0.0626	CbGeAlD
Vismodegib—CYP3A4—Irinotecan—breast cancer	0.00255	0.00627	CbGbCtD
Vismodegib—SHH—embryo—breast cancer	0.00251	0.0611	CbGeAlD
Vismodegib—ABCB1—Doxorubicin—breast cancer	0.00232	0.00572	CbGbCtD
Vismodegib—CYP3A4—Vinblastine—breast cancer	0.00226	0.00558	CbGbCtD
Vismodegib—ABCB1—Methotrexate—breast cancer	0.00225	0.00554	CbGbCtD
Vismodegib—SMO—nipple—breast cancer	0.00213	0.0518	CbGeAlD
Vismodegib—SHH—epithelium—breast cancer	0.00205	0.0498	CbGeAlD
Vismodegib—SHH—skin of body—breast cancer	0.00195	0.0474	CbGeAlD
Vismodegib—CYP3A4—Docetaxel—breast cancer	0.00187	0.0046	CbGbCtD
Vismodegib—SHH—endometrium—breast cancer	0.00183	0.0447	CbGeAlD
Vismodegib—SMO—embryo—breast cancer	0.00175	0.0427	CbGeAlD
Vismodegib—SHH—female reproductive system—breast cancer	0.00152	0.037	CbGeAlD
Vismodegib—SHH—bone marrow—breast cancer	0.00143	0.0349	CbGeAlD
Vismodegib—CYP3A4—Doxorubicin—breast cancer	0.00139	0.00343	CbGbCtD
Vismodegib—SMO—skin of body—breast cancer	0.00136	0.0331	CbGeAlD
Vismodegib—SHH—endocrine gland—breast cancer	0.00129	0.0313	CbGeAlD
Vismodegib—SMO—endometrium—breast cancer	0.00128	0.0313	CbGeAlD
Vismodegib—SMO—uterus—breast cancer	0.00118	0.0288	CbGeAlD
Vismodegib—SMO—pituitary gland—breast cancer	0.00116	0.0283	CbGeAlD
Vismodegib—SMO—adipose tissue—breast cancer	0.00116	0.0282	CbGeAlD
Vismodegib—SMO—female reproductive system—breast cancer	0.00106	0.0259	CbGeAlD
Vismodegib—SMO—adrenal gland—breast cancer	0.00104	0.0253	CbGeAlD
Vismodegib—ALB—mammary gland—breast cancer	0.000985	0.024	CbGeAlD
Vismodegib—SMO—female gonad—breast cancer	0.000967	0.0236	CbGeAlD
Vismodegib—SMO—endocrine gland—breast cancer	0.0009	0.0219	CbGeAlD
Vismodegib—CYP2C8—mammary gland—breast cancer	0.000692	0.0169	CbGeAlD
Vismodegib—SMO—lymph node—breast cancer	0.000622	0.0151	CbGeAlD
Vismodegib—CYP2C9—mammary gland—breast cancer	0.000615	0.015	CbGeAlD
Vismodegib—ORM1—endometrium—breast cancer	0.000561	0.0137	CbGeAlD
Vismodegib—Sorafenib—RAF1—breast cancer	0.000467	0.106	CrCbGaD
Vismodegib—ORM1—female reproductive system—breast cancer	0.000465	0.0113	CbGeAlD
Vismodegib—Sorafenib—FGFR1—breast cancer	0.00046	0.104	CrCbGaD
Vismodegib—Sorafenib—FLT1—breast cancer	0.000439	0.0992	CrCbGaD
Vismodegib—ORM1—bone marrow—breast cancer	0.000439	0.0107	CbGeAlD
Vismodegib—Sorafenib—CSF1R—breast cancer	0.000416	0.094	CrCbGaD
Vismodegib—ALB—adrenal gland—breast cancer	0.000398	0.00968	CbGeAlD
Vismodegib—ORM1—endocrine gland—breast cancer	0.000393	0.00957	CbGeAlD
Vismodegib—Sulfasalazine—SLCO1B1—breast cancer	0.00035	0.0791	CrCbGaD
Vismodegib—CYP2C8—endometrium—breast cancer	0.000346	0.00842	CbGeAlD
Vismodegib—ABCG2—endometrium—breast cancer	0.000336	0.00818	CbGeAlD
Vismodegib—Sorafenib—BRAF—breast cancer	0.000324	0.0731	CrCbGaD
Vismodegib—CYP2C8—pituitary gland—breast cancer	0.000313	0.00762	CbGeAlD
Vismodegib—ABCG2—uterus—breast cancer	0.00031	0.00754	CbGeAlD
Vismodegib—ABCG2—pituitary gland—breast cancer	0.000304	0.00741	CbGeAlD
Vismodegib—ABCG2—adipose tissue—breast cancer	0.000303	0.00738	CbGeAlD
Vismodegib—CYP2C8—female reproductive system—breast cancer	0.000286	0.00697	CbGeAlD
Vismodegib—CYP2C19—endocrine gland—breast cancer	0.000278	0.00676	CbGeAlD
Vismodegib—Sorafenib—KDR—breast cancer	0.000275	0.0622	CrCbGaD
Vismodegib—ORM1—lymph node—breast cancer	0.000272	0.00662	CbGeAlD
Vismodegib—ABCG2—adrenal gland—breast cancer	0.000272	0.00662	CbGeAlD
Vismodegib—ABCG2—bone marrow—breast cancer	0.000263	0.0064	CbGeAlD
Vismodegib—Sorafenib—KIT—breast cancer	0.00026	0.0587	CrCbGaD
Vismodegib—CYP2C9—female reproductive system—breast cancer	0.000254	0.00619	CbGeAlD
Vismodegib—ABCG2—female gonad—breast cancer	0.000253	0.00617	CbGeAlD
Vismodegib—CYP2C8—endocrine gland—breast cancer	0.000242	0.0059	CbGeAlD
Vismodegib—ALB—lymph node—breast cancer	0.000238	0.0058	CbGeAlD
Vismodegib—ABCB1—embryo—breast cancer	0.000226	0.00551	CbGeAlD
Vismodegib—CYP2C9—endocrine gland—breast cancer	0.000215	0.00524	CbGeAlD
Vismodegib—CYP3A4—female reproductive system—breast cancer	0.000194	0.00472	CbGeAlD
Vismodegib—ABCB1—epithelium—breast cancer	0.000185	0.0045	CbGeAlD
Vismodegib—Tolvaptan—CYP3A4—breast cancer	0.000171	0.0385	CrCbGaD
Vismodegib—ABCB1—endometrium—breast cancer	0.000166	0.00404	CbGeAlD
Vismodegib—CYP3A4—endocrine gland—breast cancer	0.000164	0.004	CbGeAlD
Vismodegib—ABCG2—lymph node—breast cancer	0.000163	0.00397	CbGeAlD
Vismodegib—ABCB1—uterus—breast cancer	0.000153	0.00372	CbGeAlD
Vismodegib—Sulfasalazine—ABCG2—breast cancer	0.000152	0.0344	CrCbGaD
Vismodegib—Etoricoxib—CYP2D6—breast cancer	0.000151	0.034	CrCbGaD
Vismodegib—ABCB1—pituitary gland—breast cancer	0.00015	0.00365	CbGeAlD
Vismodegib—ABCB1—adipose tissue—breast cancer	0.000149	0.00364	CbGeAlD
Vismodegib—Sorafenib—ABCG2—breast cancer	0.000144	0.0325	CrCbGaD
Vismodegib—Tolvaptan—ABCB1—breast cancer	0.000142	0.0321	CrCbGaD
Vismodegib—ABCB1—female reproductive system—breast cancer	0.000137	0.00334	CbGeAlD
Vismodegib—ABCB1—adrenal gland—breast cancer	0.000134	0.00326	CbGeAlD
Vismodegib—Sulfasalazine—PTGS1—breast cancer	0.000131	0.0295	CrCbGaD
Vismodegib—ABCB1—bone marrow—breast cancer	0.00013	0.00316	CbGeAlD
Vismodegib—Etoricoxib—CYP3A4—breast cancer	0.000129	0.0292	CrCbGaD
Vismodegib—Etoricoxib—PTGS2—breast cancer	0.000127	0.0286	CrCbGaD
Vismodegib—ABCB1—female gonad—breast cancer	0.000125	0.00304	CbGeAlD
Vismodegib—ABCB1—endocrine gland—breast cancer	0.000116	0.00283	CbGeAlD
Vismodegib—Nervous system disorder—Fluorouracil—breast cancer	8.75e-05	0.000698	CcSEcCtD
Vismodegib—Vomiting—Vinblastine—breast cancer	8.64e-05	0.000689	CcSEcCtD
Vismodegib—Diarrhoea—Goserelin—breast cancer	8.63e-05	0.000688	CcSEcCtD
Vismodegib—Connective tissue disorder—Capecitabine—breast cancer	8.63e-05	0.000688	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—breast cancer	8.54e-05	0.00068	CcSEcCtD
Vismodegib—Abdominal pain—Thiotepa—breast cancer	8.53e-05	0.00068	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Mitoxantrone—breast cancer	8.49e-05	0.000677	CcSEcCtD
Vismodegib—Vomiting—Tamoxifen—breast cancer	8.4e-05	0.000669	CcSEcCtD
Vismodegib—Sorafenib—CYP2D6—breast cancer	8.39e-05	0.0189	CrCbGaD
Vismodegib—Rash—Tamoxifen—breast cancer	8.33e-05	0.000664	CcSEcCtD
Vismodegib—Dermatitis—Tamoxifen—breast cancer	8.32e-05	0.000663	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Gemcitabine—breast cancer	8.27e-05	0.000659	CcSEcCtD
Vismodegib—Vomiting—Melphalan—breast cancer	8.22e-05	0.000655	CcSEcCtD
Vismodegib—Dehydration—Epirubicin—breast cancer	8.22e-05	0.000655	CcSEcCtD
Vismodegib—Hyponatraemia—Doxorubicin—breast cancer	8.21e-05	0.000655	CcSEcCtD
Vismodegib—Dyspepsia—Mitoxantrone—breast cancer	8.2e-05	0.000654	CcSEcCtD
Vismodegib—Dyspepsia—Irinotecan—breast cancer	8.2e-05	0.000654	CcSEcCtD
Vismodegib—Pain in extremity—Doxorubicin—breast cancer	8.18e-05	0.000652	CcSEcCtD
Vismodegib—Rash—Melphalan—breast cancer	8.15e-05	0.00065	CcSEcCtD
Vismodegib—Dermatitis—Melphalan—breast cancer	8.15e-05	0.000649	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Fluorouracil—breast cancer	8.13e-05	0.000648	CcSEcCtD
Vismodegib—Asthenia—Vinorelbine—breast cancer	8.11e-05	0.000646	CcSEcCtD
Vismodegib—Decreased appetite—Mitoxantrone—breast cancer	8.1e-05	0.000646	CcSEcCtD
Vismodegib—Decreased appetite—Irinotecan—breast cancer	8.1e-05	0.000646	CcSEcCtD
Vismodegib—Nausea—Vinblastine—breast cancer	8.07e-05	0.000644	CcSEcCtD
Vismodegib—Abdominal pain upper—Epirubicin—breast cancer	8.07e-05	0.000644	CcSEcCtD
Vismodegib—Hypokalaemia—Epirubicin—breast cancer	8.04e-05	0.000641	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Irinotecan—breast cancer	8.04e-05	0.000641	CcSEcCtD
Vismodegib—Fatigue—Irinotecan—breast cancer	8.03e-05	0.00064	CcSEcCtD
Vismodegib—Fatigue—Mitoxantrone—breast cancer	8.03e-05	0.00064	CcSEcCtD
Vismodegib—ABCB1—lymph node—breast cancer	8.03e-05	0.00196	CbGeAlD
Vismodegib—Vomiting—Goserelin—breast cancer	8.02e-05	0.000639	CcSEcCtD
Vismodegib—Alopecia—Docetaxel—breast cancer	8.01e-05	0.000639	CcSEcCtD
Vismodegib—Pruritus—Vinorelbine—breast cancer	7.99e-05	0.000637	CcSEcCtD
Vismodegib—Breast disorder—Epirubicin—breast cancer	7.99e-05	0.000637	CcSEcCtD
Vismodegib—Pain—Mitoxantrone—breast cancer	7.97e-05	0.000635	CcSEcCtD
Vismodegib—Constipation—Irinotecan—breast cancer	7.97e-05	0.000635	CcSEcCtD
Vismodegib—Pain—Irinotecan—breast cancer	7.97e-05	0.000635	CcSEcCtD
Vismodegib—Constipation—Mitoxantrone—breast cancer	7.97e-05	0.000635	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Epirubicin—breast cancer	7.96e-05	0.000634	CcSEcCtD
Vismodegib—Rash—Goserelin—breast cancer	7.95e-05	0.000634	CcSEcCtD
Vismodegib—Dermatitis—Goserelin—breast cancer	7.95e-05	0.000633	CcSEcCtD
Vismodegib—Arthralgia—Paclitaxel—breast cancer	7.93e-05	0.000632	CcSEcCtD
Vismodegib—Myalgia—Paclitaxel—breast cancer	7.93e-05	0.000632	CcSEcCtD
Vismodegib—Malnutrition—Docetaxel—breast cancer	7.89e-05	0.000629	CcSEcCtD
Vismodegib—Decreased appetite—Gemcitabine—breast cancer	7.89e-05	0.000629	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	7.87e-05	0.000628	CcSEcCtD
Vismodegib—Dyspepsia—Fluorouracil—breast cancer	7.86e-05	0.000626	CcSEcCtD
Vismodegib—Nausea—Tamoxifen—breast cancer	7.84e-05	0.000625	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Gemcitabine—breast cancer	7.84e-05	0.000625	CcSEcCtD
Vismodegib—Fatigue—Gemcitabine—breast cancer	7.83e-05	0.000624	CcSEcCtD
Vismodegib—Constipation—Gemcitabine—breast cancer	7.76e-05	0.000619	CcSEcCtD
Vismodegib—Pain—Gemcitabine—breast cancer	7.76e-05	0.000619	CcSEcCtD
Vismodegib—Decreased appetite—Fluorouracil—breast cancer	7.76e-05	0.000618	CcSEcCtD
Vismodegib—Alopecia—Capecitabine—breast cancer	7.76e-05	0.000618	CcSEcCtD
Vismodegib—Asthenia—Thiotepa—breast cancer	7.74e-05	0.000617	CcSEcCtD
Vismodegib—Diarrhoea—Vinorelbine—breast cancer	7.73e-05	0.000616	CcSEcCtD
Vismodegib—Dysgeusia—Docetaxel—breast cancer	7.73e-05	0.000616	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Fluorouracil—breast cancer	7.7e-05	0.000614	CcSEcCtD
Vismodegib—Nausea—Melphalan—breast cancer	7.68e-05	0.000612	CcSEcCtD
Vismodegib—Malnutrition—Capecitabine—breast cancer	7.64e-05	0.000609	CcSEcCtD
Vismodegib—Back pain—Docetaxel—breast cancer	7.63e-05	0.000609	CcSEcCtD
Vismodegib—Pruritus—Thiotepa—breast cancer	7.63e-05	0.000608	CcSEcCtD
Vismodegib—Pain—Fluorouracil—breast cancer	7.63e-05	0.000608	CcSEcCtD
Vismodegib—Gastrointestinal pain—Irinotecan—breast cancer	7.62e-05	0.000607	CcSEcCtD
Vismodegib—Gastrointestinal pain—Mitoxantrone—breast cancer	7.62e-05	0.000607	CcSEcCtD
Vismodegib—Dehydration—Doxorubicin—breast cancer	7.61e-05	0.000606	CcSEcCtD
Vismodegib—Muscle spasms—Docetaxel—breast cancer	7.59e-05	0.000605	CcSEcCtD
Vismodegib—Nausea—Goserelin—breast cancer	7.49e-05	0.000597	CcSEcCtD
Vismodegib—Dysgeusia—Capecitabine—breast cancer	7.48e-05	0.000596	CcSEcCtD
Vismodegib—Abdominal pain upper—Doxorubicin—breast cancer	7.47e-05	0.000595	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—breast cancer	7.46e-05	0.0169	CrCbGaD
Vismodegib—Nervous system disorder—Paclitaxel—breast cancer	7.45e-05	0.000594	CcSEcCtD
Vismodegib—Hypokalaemia—Doxorubicin—breast cancer	7.44e-05	0.000593	CcSEcCtD
Vismodegib—Back pain—Capecitabine—breast cancer	7.39e-05	0.000589	CcSEcCtD
Vismodegib—Breast disorder—Doxorubicin—breast cancer	7.39e-05	0.000589	CcSEcCtD
Vismodegib—Diarrhoea—Thiotepa—breast cancer	7.38e-05	0.000588	CcSEcCtD
Vismodegib—Skin disorder—Paclitaxel—breast cancer	7.38e-05	0.000588	CcSEcCtD
Vismodegib—Abdominal pain—Mitoxantrone—breast cancer	7.37e-05	0.000587	CcSEcCtD
Vismodegib—Abdominal pain—Irinotecan—breast cancer	7.37e-05	0.000587	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Doxorubicin—breast cancer	7.36e-05	0.000587	CcSEcCtD
Vismodegib—Muscle spasms—Capecitabine—breast cancer	7.35e-05	0.000586	CcSEcCtD
Vismodegib—Sorafenib—CYP3A4—breast cancer	7.19e-05	0.0162	CrCbGaD
Vismodegib—Vomiting—Vinorelbine—breast cancer	7.18e-05	0.000573	CcSEcCtD
Vismodegib—Rash—Vinorelbine—breast cancer	7.12e-05	0.000568	CcSEcCtD
Vismodegib—Dermatitis—Vinorelbine—breast cancer	7.12e-05	0.000567	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.92e-05	0.000552	CcSEcCtD
Vismodegib—Weight decreased—Epirubicin—breast cancer	6.91e-05	0.000551	CcSEcCtD
Vismodegib—Vomiting—Thiotepa—breast cancer	6.86e-05	0.000547	CcSEcCtD
Vismodegib—Rash—Thiotepa—breast cancer	6.8e-05	0.000542	CcSEcCtD
Vismodegib—Dermatitis—Thiotepa—breast cancer	6.8e-05	0.000542	CcSEcCtD
Vismodegib—Myalgia—Docetaxel—breast cancer	6.72e-05	0.000536	CcSEcCtD
Vismodegib—Arthralgia—Docetaxel—breast cancer	6.72e-05	0.000536	CcSEcCtD
Vismodegib—Nausea—Vinorelbine—breast cancer	6.71e-05	0.000535	CcSEcCtD
Vismodegib—Dyspepsia—Paclitaxel—breast cancer	6.69e-05	0.000533	CcSEcCtD
Vismodegib—Asthenia—Mitoxantrone—breast cancer	6.69e-05	0.000533	CcSEcCtD
Vismodegib—Asthenia—Irinotecan—breast cancer	6.69e-05	0.000533	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.67e-05	0.000532	CcSEcCtD
Vismodegib—Decreased appetite—Paclitaxel—breast cancer	6.61e-05	0.000527	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Paclitaxel—breast cancer	6.56e-05	0.000523	CcSEcCtD
Vismodegib—Fatigue—Paclitaxel—breast cancer	6.55e-05	0.000522	CcSEcCtD
Vismodegib—Asthenia—Gemcitabine—breast cancer	6.51e-05	0.000519	CcSEcCtD
Vismodegib—Arthralgia—Capecitabine—breast cancer	6.51e-05	0.000519	CcSEcCtD
Vismodegib—Myalgia—Capecitabine—breast cancer	6.51e-05	0.000519	CcSEcCtD
Vismodegib—Pain—Paclitaxel—breast cancer	6.5e-05	0.000518	CcSEcCtD
Vismodegib—Constipation—Paclitaxel—breast cancer	6.5e-05	0.000518	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.46e-05	0.000515	CcSEcCtD
Vismodegib—Pruritus—Gemcitabine—breast cancer	6.42e-05	0.000512	CcSEcCtD
Vismodegib—Nausea—Thiotepa—breast cancer	6.41e-05	0.000511	CcSEcCtD
Vismodegib—Weight decreased—Doxorubicin—breast cancer	6.4e-05	0.00051	CcSEcCtD
Vismodegib—Diarrhoea—Mitoxantrone—breast cancer	6.38e-05	0.000508	CcSEcCtD
Vismodegib—Diarrhoea—Irinotecan—breast cancer	6.38e-05	0.000508	CcSEcCtD
Vismodegib—Nervous system disorder—Docetaxel—breast cancer	6.32e-05	0.000503	CcSEcCtD
Vismodegib—Pruritus—Fluorouracil—breast cancer	6.31e-05	0.000503	CcSEcCtD
Vismodegib—Skin disorder—Docetaxel—breast cancer	6.26e-05	0.000499	CcSEcCtD
Vismodegib—Gastrointestinal pain—Paclitaxel—breast cancer	6.21e-05	0.000495	CcSEcCtD
Vismodegib—Diarrhoea—Gemcitabine—breast cancer	6.21e-05	0.000495	CcSEcCtD
Vismodegib—Nervous system disorder—Capecitabine—breast cancer	6.12e-05	0.000487	CcSEcCtD
Vismodegib—Diarrhoea—Fluorouracil—breast cancer	6.11e-05	0.000487	CcSEcCtD
Vismodegib—Skin disorder—Capecitabine—breast cancer	6.06e-05	0.000483	CcSEcCtD
Vismodegib—Connective tissue disorder—Epirubicin—breast cancer	6.01e-05	0.000479	CcSEcCtD
Vismodegib—Abdominal pain—Paclitaxel—breast cancer	6.01e-05	0.000479	CcSEcCtD
Vismodegib—Sorafenib—ABCB1—breast cancer	5.99e-05	0.0135	CrCbGaD
Vismodegib—Vomiting—Mitoxantrone—breast cancer	5.92e-05	0.000472	CcSEcCtD
Vismodegib—Vomiting—Irinotecan—breast cancer	5.92e-05	0.000472	CcSEcCtD
Vismodegib—Rash—Irinotecan—breast cancer	5.87e-05	0.000468	CcSEcCtD
Vismodegib—Rash—Mitoxantrone—breast cancer	5.87e-05	0.000468	CcSEcCtD
Vismodegib—Dermatitis—Mitoxantrone—breast cancer	5.87e-05	0.000468	CcSEcCtD
Vismodegib—Dermatitis—Irinotecan—breast cancer	5.87e-05	0.000468	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Docetaxel—breast cancer	5.87e-05	0.000468	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—breast cancer	5.77e-05	0.00046	CcSEcCtD
Vismodegib—Vomiting—Gemcitabine—breast cancer	5.77e-05	0.00046	CcSEcCtD
Vismodegib—Rash—Gemcitabine—breast cancer	5.72e-05	0.000456	CcSEcCtD
Vismodegib—Dermatitis—Gemcitabine—breast cancer	5.72e-05	0.000456	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—breast cancer	5.69e-05	0.000453	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Capecitabine—breast cancer	5.68e-05	0.000453	CcSEcCtD
Vismodegib—Vomiting—Fluorouracil—breast cancer	5.67e-05	0.000452	CcSEcCtD
Vismodegib—Dyspepsia—Docetaxel—breast cancer	5.67e-05	0.000452	CcSEcCtD
Vismodegib—Rash—Fluorouracil—breast cancer	5.63e-05	0.000449	CcSEcCtD
Vismodegib—Dermatitis—Fluorouracil—breast cancer	5.62e-05	0.000448	CcSEcCtD
Vismodegib—Decreased appetite—Docetaxel—breast cancer	5.6e-05	0.000446	CcSEcCtD
Vismodegib—Dysgeusia—Methotrexate—breast cancer	5.57e-05	0.000444	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Docetaxel—breast cancer	5.56e-05	0.000443	CcSEcCtD
Vismodegib—Connective tissue disorder—Doxorubicin—breast cancer	5.56e-05	0.000443	CcSEcCtD
Vismodegib—Fatigue—Docetaxel—breast cancer	5.55e-05	0.000443	CcSEcCtD
Vismodegib—Nausea—Irinotecan—breast cancer	5.53e-05	0.000441	CcSEcCtD
Vismodegib—Nausea—Mitoxantrone—breast cancer	5.53e-05	0.000441	CcSEcCtD
Vismodegib—Pain—Docetaxel—breast cancer	5.51e-05	0.000439	CcSEcCtD
Vismodegib—Constipation—Docetaxel—breast cancer	5.51e-05	0.000439	CcSEcCtD
Vismodegib—Back pain—Methotrexate—breast cancer	5.5e-05	0.000439	CcSEcCtD
Vismodegib—Dyspepsia—Capecitabine—breast cancer	5.49e-05	0.000438	CcSEcCtD
Vismodegib—Asthenia—Paclitaxel—breast cancer	5.45e-05	0.000435	CcSEcCtD
Vismodegib—Decreased appetite—Capecitabine—breast cancer	5.42e-05	0.000432	CcSEcCtD
Vismodegib—Alopecia—Epirubicin—breast cancer	5.4e-05	0.000431	CcSEcCtD
Vismodegib—Nausea—Gemcitabine—breast cancer	5.39e-05	0.00043	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Capecitabine—breast cancer	5.38e-05	0.000429	CcSEcCtD
Vismodegib—Fatigue—Capecitabine—breast cancer	5.38e-05	0.000429	CcSEcCtD
Vismodegib—Pruritus—Paclitaxel—breast cancer	5.38e-05	0.000429	CcSEcCtD
Vismodegib—Pain—Capecitabine—breast cancer	5.33e-05	0.000425	CcSEcCtD
Vismodegib—Constipation—Capecitabine—breast cancer	5.33e-05	0.000425	CcSEcCtD
Vismodegib—Malnutrition—Epirubicin—breast cancer	5.32e-05	0.000424	CcSEcCtD
Vismodegib—Nausea—Fluorouracil—breast cancer	5.3e-05	0.000423	CcSEcCtD
Vismodegib—Gastrointestinal pain—Docetaxel—breast cancer	5.27e-05	0.00042	CcSEcCtD
Vismodegib—Dysgeusia—Epirubicin—breast cancer	5.21e-05	0.000416	CcSEcCtD
Vismodegib—Diarrhoea—Paclitaxel—breast cancer	5.2e-05	0.000414	CcSEcCtD
Vismodegib—Back pain—Epirubicin—breast cancer	5.15e-05	0.00041	CcSEcCtD
Vismodegib—Muscle spasms—Epirubicin—breast cancer	5.12e-05	0.000408	CcSEcCtD
Vismodegib—Gastrointestinal pain—Capecitabine—breast cancer	5.1e-05	0.000406	CcSEcCtD
Vismodegib—Abdominal pain—Docetaxel—breast cancer	5.09e-05	0.000406	CcSEcCtD
Vismodegib—Alopecia—Doxorubicin—breast cancer	5e-05	0.000399	CcSEcCtD
Vismodegib—Abdominal pain—Capecitabine—breast cancer	4.93e-05	0.000393	CcSEcCtD
Vismodegib—Malnutrition—Doxorubicin—breast cancer	4.93e-05	0.000393	CcSEcCtD
Vismodegib—Arthralgia—Methotrexate—breast cancer	4.84e-05	0.000386	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—breast cancer	4.84e-05	0.000386	CcSEcCtD
Vismodegib—Vomiting—Paclitaxel—breast cancer	4.83e-05	0.000385	CcSEcCtD
Vismodegib—Dysgeusia—Doxorubicin—breast cancer	4.82e-05	0.000384	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.81e-05	0.000383	CcSEcCtD
Vismodegib—Rash—Paclitaxel—breast cancer	4.79e-05	0.000382	CcSEcCtD
Vismodegib—Dermatitis—Paclitaxel—breast cancer	4.79e-05	0.000382	CcSEcCtD
Vismodegib—Back pain—Doxorubicin—breast cancer	4.76e-05	0.00038	CcSEcCtD
Vismodegib—Muscle spasms—Doxorubicin—breast cancer	4.74e-05	0.000377	CcSEcCtD
Vismodegib—Asthenia—Docetaxel—breast cancer	4.62e-05	0.000368	CcSEcCtD
Vismodegib—Pruritus—Docetaxel—breast cancer	4.56e-05	0.000363	CcSEcCtD
Vismodegib—Nervous system disorder—Methotrexate—breast cancer	4.55e-05	0.000363	CcSEcCtD
Vismodegib—Myalgia—Epirubicin—breast cancer	4.53e-05	0.000361	CcSEcCtD
Vismodegib—Arthralgia—Epirubicin—breast cancer	4.53e-05	0.000361	CcSEcCtD
Vismodegib—Nausea—Paclitaxel—breast cancer	4.51e-05	0.00036	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—breast cancer	4.51e-05	0.000359	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.5e-05	0.000359	CcSEcCtD
Vismodegib—Asthenia—Capecitabine—breast cancer	4.47e-05	0.000357	CcSEcCtD
Vismodegib—Pruritus—Capecitabine—breast cancer	4.41e-05	0.000352	CcSEcCtD
Vismodegib—Diarrhoea—Docetaxel—breast cancer	4.41e-05	0.000351	CcSEcCtD
Vismodegib—Diarrhoea—Capecitabine—breast cancer	4.27e-05	0.00034	CcSEcCtD
Vismodegib—Nervous system disorder—Epirubicin—breast cancer	4.26e-05	0.00034	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methotrexate—breast cancer	4.23e-05	0.000337	CcSEcCtD
Vismodegib—Skin disorder—Epirubicin—breast cancer	4.22e-05	0.000336	CcSEcCtD
Vismodegib—Arthralgia—Doxorubicin—breast cancer	4.19e-05	0.000334	CcSEcCtD
Vismodegib—Myalgia—Doxorubicin—breast cancer	4.19e-05	0.000334	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.16e-05	0.000332	CcSEcCtD
Vismodegib—Vomiting—Docetaxel—breast cancer	4.1e-05	0.000326	CcSEcCtD
Vismodegib—Dyspepsia—Methotrexate—breast cancer	4.09e-05	0.000326	CcSEcCtD
Vismodegib—Rash—Docetaxel—breast cancer	4.06e-05	0.000324	CcSEcCtD
Vismodegib—Dermatitis—Docetaxel—breast cancer	4.06e-05	0.000323	CcSEcCtD
Vismodegib—Decreased appetite—Methotrexate—breast cancer	4.04e-05	0.000322	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methotrexate—breast cancer	4.01e-05	0.000319	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—breast cancer	4e-05	0.000319	CcSEcCtD
Vismodegib—Pain—Methotrexate—breast cancer	3.97e-05	0.000316	CcSEcCtD
Vismodegib—Vomiting—Capecitabine—breast cancer	3.96e-05	0.000316	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Epirubicin—breast cancer	3.96e-05	0.000316	CcSEcCtD
Vismodegib—Nervous system disorder—Doxorubicin—breast cancer	3.94e-05	0.000314	CcSEcCtD
Vismodegib—Rash—Capecitabine—breast cancer	3.93e-05	0.000313	CcSEcCtD
Vismodegib—Dermatitis—Capecitabine—breast cancer	3.93e-05	0.000313	CcSEcCtD
Vismodegib—Skin disorder—Doxorubicin—breast cancer	3.9e-05	0.000311	CcSEcCtD
Vismodegib—Nausea—Docetaxel—breast cancer	3.83e-05	0.000305	CcSEcCtD
Vismodegib—Dyspepsia—Epirubicin—breast cancer	3.82e-05	0.000305	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methotrexate—breast cancer	3.8e-05	0.000303	CcSEcCtD
Vismodegib—Decreased appetite—Epirubicin—breast cancer	3.78e-05	0.000301	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Epirubicin—breast cancer	3.75e-05	0.000299	CcSEcCtD
Vismodegib—Fatigue—Epirubicin—breast cancer	3.75e-05	0.000299	CcSEcCtD
Vismodegib—Pain—Epirubicin—breast cancer	3.72e-05	0.000296	CcSEcCtD
Vismodegib—Constipation—Epirubicin—breast cancer	3.72e-05	0.000296	CcSEcCtD
Vismodegib—Nausea—Capecitabine—breast cancer	3.7e-05	0.000295	CcSEcCtD
Vismodegib—Abdominal pain—Methotrexate—breast cancer	3.67e-05	0.000293	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.66e-05	0.000292	CcSEcCtD
Vismodegib—Gastrointestinal pain—Epirubicin—breast cancer	3.55e-05	0.000283	CcSEcCtD
Vismodegib—Dyspepsia—Doxorubicin—breast cancer	3.54e-05	0.000282	CcSEcCtD
Vismodegib—Decreased appetite—Doxorubicin—breast cancer	3.49e-05	0.000279	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Doxorubicin—breast cancer	3.47e-05	0.000277	CcSEcCtD
Vismodegib—Fatigue—Doxorubicin—breast cancer	3.47e-05	0.000276	CcSEcCtD
Vismodegib—Pain—Doxorubicin—breast cancer	3.44e-05	0.000274	CcSEcCtD
Vismodegib—Constipation—Doxorubicin—breast cancer	3.44e-05	0.000274	CcSEcCtD
Vismodegib—Abdominal pain—Epirubicin—breast cancer	3.43e-05	0.000274	CcSEcCtD
Vismodegib—Asthenia—Methotrexate—breast cancer	3.33e-05	0.000265	CcSEcCtD
Vismodegib—Gastrointestinal pain—Doxorubicin—breast cancer	3.29e-05	0.000262	CcSEcCtD
Vismodegib—Pruritus—Methotrexate—breast cancer	3.28e-05	0.000262	CcSEcCtD
Vismodegib—Abdominal pain—Doxorubicin—breast cancer	3.18e-05	0.000253	CcSEcCtD
Vismodegib—Diarrhoea—Methotrexate—breast cancer	3.18e-05	0.000253	CcSEcCtD
Vismodegib—Asthenia—Epirubicin—breast cancer	3.12e-05	0.000248	CcSEcCtD
Vismodegib—Pruritus—Epirubicin—breast cancer	3.07e-05	0.000245	CcSEcCtD
Vismodegib—Diarrhoea—Epirubicin—breast cancer	2.97e-05	0.000237	CcSEcCtD
Vismodegib—Vomiting—Methotrexate—breast cancer	2.95e-05	0.000235	CcSEcCtD
Vismodegib—Rash—Methotrexate—breast cancer	2.93e-05	0.000233	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—breast cancer	2.92e-05	0.000233	CcSEcCtD
Vismodegib—Asthenia—Doxorubicin—breast cancer	2.88e-05	0.00023	CcSEcCtD
Vismodegib—Pruritus—Doxorubicin—breast cancer	2.84e-05	0.000227	CcSEcCtD
Vismodegib—Vomiting—Epirubicin—breast cancer	2.76e-05	0.00022	CcSEcCtD
Vismodegib—Nausea—Methotrexate—breast cancer	2.76e-05	0.00022	CcSEcCtD
Vismodegib—Diarrhoea—Doxorubicin—breast cancer	2.75e-05	0.000219	CcSEcCtD
Vismodegib—Rash—Epirubicin—breast cancer	2.74e-05	0.000218	CcSEcCtD
Vismodegib—Dermatitis—Epirubicin—breast cancer	2.74e-05	0.000218	CcSEcCtD
Vismodegib—Nausea—Epirubicin—breast cancer	2.58e-05	0.000206	CcSEcCtD
Vismodegib—Vomiting—Doxorubicin—breast cancer	2.56e-05	0.000204	CcSEcCtD
Vismodegib—Rash—Doxorubicin—breast cancer	2.53e-05	0.000202	CcSEcCtD
Vismodegib—Dermatitis—Doxorubicin—breast cancer	2.53e-05	0.000202	CcSEcCtD
Vismodegib—Nausea—Doxorubicin—breast cancer	2.39e-05	0.00019	CcSEcCtD
Vismodegib—CYP2C19—Metabolism—BCHE—breast cancer	2.63e-06	2.48e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HSP90AA1—breast cancer	2.63e-06	2.48e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP17A1—breast cancer	2.6e-06	2.46e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC5A5—breast cancer	2.6e-06	2.45e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS1—breast cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ENO1—breast cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—FASN—breast cancer	2.58e-06	2.43e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CG—breast cancer	2.58e-06	2.43e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NCOA1—breast cancer	2.57e-06	2.43e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.57e-06	2.43e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—BCHE—breast cancer	2.57e-06	2.42e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NCOA1—breast cancer	2.55e-06	2.41e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.54e-06	2.4e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC5A5—breast cancer	2.53e-06	2.39e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—STK11—breast cancer	2.53e-06	2.39e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP19A1—breast cancer	2.53e-06	2.39e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2D6—breast cancer	2.53e-06	2.39e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—STK11—breast cancer	2.52e-06	2.38e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP19A1—breast cancer	2.52e-06	2.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA4—breast cancer	2.52e-06	2.38e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA9—breast cancer	2.52e-06	2.38e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A1—breast cancer	2.51e-06	2.37e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NQO1—breast cancer	2.51e-06	2.37e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NCOA2—breast cancer	2.48e-06	2.34e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.46e-06	2.32e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA2—breast cancer	2.45e-06	2.32e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX2—breast cancer	2.45e-06	2.32e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NQO1—breast cancer	2.45e-06	2.31e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A1—breast cancer	2.45e-06	2.31e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP3A4—breast cancer	2.45e-06	2.31e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.43e-06	2.3e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX4—breast cancer	2.42e-06	2.29e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SULT1A1—breast cancer	2.42e-06	2.29e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SRC—breast cancer	2.41e-06	2.27e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—FASN—breast cancer	2.41e-06	2.27e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1B1—breast cancer	2.4e-06	2.27e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—BCHE—breast cancer	2.4e-06	2.26e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP3A4—breast cancer	2.39e-06	2.25e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.38e-06	2.25e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC5A5—breast cancer	2.37e-06	2.24e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—IDH1—breast cancer	2.37e-06	2.24e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA1—breast cancer	2.37e-06	2.24e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.36e-06	2.23e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.36e-06	2.23e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—COMT—breast cancer	2.35e-06	2.22e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1B1—breast cancer	2.35e-06	2.22e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—breast cancer	2.34e-06	2.22e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTP1—breast cancer	2.34e-06	2.21e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—COMT—breast cancer	2.34e-06	2.21e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NAT2—breast cancer	2.34e-06	2.21e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.33e-06	2.2e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTP1—breast cancer	2.33e-06	2.2e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—HMOX1—breast cancer	2.31e-06	2.18e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ITPR1—breast cancer	2.31e-06	2.18e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HSP90AA1—breast cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—HMOX1—breast cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NCOA1—breast cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ITPR1—breast cancer	2.29e-06	2.17e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A1—breast cancer	2.29e-06	2.16e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NQO1—breast cancer	2.29e-06	2.16e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CD—breast cancer	2.26e-06	2.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP19A1—breast cancer	2.26e-06	2.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—STK11—breast cancer	2.26e-06	2.14e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NCOA1—breast cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—breast cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP3A4—breast cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.22e-06	2.1e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK3—breast cancer	2.22e-06	2.1e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—breast cancer	2.22e-06	2.1e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—STK11—breast cancer	2.21e-06	2.08e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP19A1—breast cancer	2.21e-06	2.08e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—breast cancer	2.21e-06	2.08e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1B1—breast cancer	2.19e-06	2.07e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TYMS—breast cancer	2.18e-06	2.06e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TYMS—breast cancer	2.17e-06	2.05e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NCOR1—breast cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—breast cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—breast cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.15e-06	2.03e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PLA2G4A—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NCOR1—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NOS3—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.12e-06	2e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—COMT—breast cancer	2.1e-06	1.99e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTP1—breast cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NCOA1—breast cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HMOX1—breast cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—breast cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP19A1—breast cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—STK11—breast cancer	2.06e-06	1.95e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ITPR1—breast cancer	2.06e-06	1.94e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—DPYD—breast cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MED12—breast cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—COMT—breast cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—breast cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTP1—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—breast cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ERCC2—breast cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDOA—breast cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HMOX1—breast cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ERCC2—breast cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ITPR1—breast cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KRAS—breast cancer	1.99e-06	1.88e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—breast cancer	1.98e-06	1.87e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CB—breast cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOA3—breast cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—breast cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A2—breast cancer	1.95e-06	1.84e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TYMS—breast cancer	1.94e-06	1.84e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.93e-06	1.83e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NCOR1—breast cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—breast cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—COMT—breast cancer	1.92e-06	1.81e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTR—breast cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCG2—breast cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CPT1A—breast cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTP1—breast cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—breast cancer	1.9e-06	1.8e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TYMS—breast cancer	1.9e-06	1.79e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—breast cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HMOX1—breast cancer	1.88e-06	1.78e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ITPR1—breast cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PLA2G4A—breast cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NCOR1—breast cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—breast cancer	1.88e-06	1.77e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HPGDS—breast cancer	1.87e-06	1.77e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HBA1—breast cancer	1.86e-06	1.76e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—breast cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CA—breast cancer	1.83e-06	1.73e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—breast cancer	1.82e-06	1.72e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTT1—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ACHE—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ERCC2—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—breast cancer	1.8e-06	1.7e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—breast cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TYMS—breast cancer	1.77e-06	1.67e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—breast cancer	1.77e-06	1.67e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ERCC2—breast cancer	1.76e-06	1.67e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CAV1—breast cancer	1.76e-06	1.66e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NCOR1—breast cancer	1.75e-06	1.66e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—breast cancer	1.75e-06	1.66e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.75e-06	1.66e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CAV1—breast cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP17A1—breast cancer	1.72e-06	1.62e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTEN—breast cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ENO1—breast cancer	1.7e-06	1.61e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS1—breast cancer	1.7e-06	1.61e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—breast cancer	1.7e-06	1.6e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—breast cancer	1.69e-06	1.6e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—breast cancer	1.68e-06	1.59e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.67e-06	1.58e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2D6—breast cancer	1.67e-06	1.58e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—breast cancer	1.66e-06	1.57e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—breast cancer	1.66e-06	1.57e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ERCC2—breast cancer	1.65e-06	1.56e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOA2—breast cancer	1.64e-06	1.55e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CG—breast cancer	1.6e-06	1.51e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CG—breast cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—FASN—breast cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—BCHE—breast cancer	1.58e-06	1.49e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CAV1—breast cancer	1.57e-06	1.48e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC5A5—breast cancer	1.56e-06	1.47e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—breast cancer	1.55e-06	1.46e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CAV1—breast cancer	1.53e-06	1.44e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NQO1—breast cancer	1.51e-06	1.42e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A1—breast cancer	1.51e-06	1.42e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—breast cancer	1.5e-06	1.41e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1B1—breast cancer	1.45e-06	1.37e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CAV1—breast cancer	1.43e-06	1.35e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CG—breast cancer	1.43e-06	1.35e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CD—breast cancer	1.41e-06	1.33e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CD—breast cancer	1.4e-06	1.32e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CG—breast cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—breast cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOA1—breast cancer	1.38e-06	1.3e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.36e-06	1.29e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—STK11—breast cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP19A1—breast cancer	1.36e-06	1.28e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NOS3—breast cancer	1.33e-06	1.25e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NOS3—breast cancer	1.32e-06	1.25e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CG—breast cancer	1.3e-06	1.23e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—COMT—breast cancer	1.26e-06	1.19e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTP1—breast cancer	1.26e-06	1.19e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CD—breast cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HMOX1—breast cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—breast cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ITPR1—breast cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CB—breast cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CD—breast cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CB—breast cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—breast cancer	1.21e-06	1.15e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—breast cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—breast cancer	1.21e-06	1.14e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CA—breast cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—breast cancer	1.19e-06	1.12e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NOS3—breast cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TYMS—breast cancer	1.17e-06	1.1e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NOS3—breast cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOR1—breast cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—breast cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CD—breast cancer	1.14e-06	1.08e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—breast cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—breast cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—breast cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CB—breast cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ERCC2—breast cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—breast cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NOS3—breast cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CB—breast cancer	1.07e-06	1.01e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTEN—breast cancer	1.06e-06	1e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—breast cancer	1.06e-06	9.99e-06	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTEN—breast cancer	1.05e-06	9.94e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—breast cancer	1.02e-06	9.65e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CB—breast cancer	9.97e-07	9.42e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—breast cancer	9.88e-07	9.33e-06	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—breast cancer	9.83e-07	9.29e-06	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTEN—breast cancer	9.45e-07	8.93e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CAV1—breast cancer	9.42e-07	8.9e-06	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTEN—breast cancer	9.22e-07	8.71e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTEN—breast cancer	8.62e-07	8.14e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CG—breast cancer	8.58e-07	8.11e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CD—breast cancer	7.54e-07	7.13e-06	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CA—breast cancer	7.47e-07	7.06e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—breast cancer	7.45e-07	7.04e-06	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CA—breast cancer	7.43e-07	7.01e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NOS3—breast cancer	7.12e-07	6.73e-06	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CA—breast cancer	6.67e-07	6.3e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CB—breast cancer	6.58e-07	6.21e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—breast cancer	6.52e-07	6.16e-06	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CA—breast cancer	6.51e-07	6.15e-06	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—breast cancer	6.1e-07	5.76e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CA—breast cancer	6.08e-07	5.74e-06	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—breast cancer	6.07e-07	5.73e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTEN—breast cancer	5.68e-07	5.37e-06	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—breast cancer	5.45e-07	5.14e-06	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—breast cancer	5.31e-07	5.02e-06	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—breast cancer	4.97e-07	4.69e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CA—breast cancer	4.01e-07	3.79e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—breast cancer	3.27e-07	3.09e-06	CbGpPWpGaD
